Market News (Page 79) - TendieTensor

Market News Page 79 of 163 • 4,051 articles

Corbion reports the progress of its share buyback program 3 November – 7 November 2025

GlobeNewswire Inc. • Corbion

Corbion reports the progress of its share buyback program 3 November – 7 November 2025

11/10/2025 01:00 AM • Corbion reported its ongoing share buyback program, repurchasing 124.786 shares at an average price of €17.6422, totaling €2,201,503.94. The company also signed a new USD 100 million debt issuance in the US Private Placement market with a 5.11% fixed interest rate.

CSNVY - The company is executing standard financial strategies like share repurchase and debt issuance, which indicate routine corporate financial management without significant positive or negative implications

#share buyback #debt issuance #private placement #financial transaction

VALLOUREC ANNOUNCES MULTI MILLION DOLLAR INVESTMENT IN A NEW PREMIUM THREADING LINE IN YOUNGSTOWN, OHIO

GlobeNewswire Inc. • Vallourec

VALLOUREC ANNOUNCES MULTI MILLION DOLLAR INVESTMENT IN A NEW PREMIUM THREADING LINE IN YOUNGSTOWN, OHIO

11/10/2025 01:00 AM • Vallourec is investing $48 million to create a new Premium Threading Line in Youngstown, Ohio, expanding its U.S. manufacturing capabilities and increasing capacity for threading high-torque connections for onshore wells.

NVDA - Mentioned in context of AI developments, with stock showing positive movement
VLOWY - The company is making a significant $48 million investment to expand operations, create 40 new jobs, and strengthen its position in the U.S. manufacturing and energy markets

#manufacturing #investment #tubular solutions #energy #Ohio

Rumble to Acquire AI Infrastructure Company Northern Data

Benzinga • Globe Newswire

Rumble to Acquire AI Infrastructure Company Northern Data

11/10/2025 12:53 AM • Rumble Inc. has signed a business combination agreement to acquire Northern Data AG, a leader in AI and high-performance computing infrastructure, through a voluntary public exchange offer that will add approximately 22,000 Nvidia GPUs and expand Rumble's international data center presence.

RUM - Acquiring Northern Data will significantly expand Rumble's cloud and AI capabilities, provide international expansion, and accelerate their technology roadmap

#AI #infrastructure #acquisition #GPU #data centers #technology

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

11/09/2025 10:56 PM • Rosen Law Firm alerts Cytokinetics investors about a securities class action lawsuit regarding potential misleading statements about a New Drug Application timeline and FDA approval process for aficamten.

MDT - Diversified medical device portfolio, FDA-approved innovative technologies, potential growth from business restructuring, and long-standing dividend track record
CYTK - The lawsuit alleges the company made false or misleading statements about its drug approval timeline and failed to disclose material risks related to its regulatory submission, suggesting potential investor harm

#securities class action #FDA #drug approval #investor rights

FLY Investor News: If You Have Suffered Losses in Firefly Aerospace Inc. (NASDAQ: FLY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

FLY Investor News: If You Have Suffered Losses in Firefly Aerospace Inc. (NASDAQ: FLY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

11/09/2025 10:47 PM • Rosen Law Firm is investigating potential securities claims for Firefly Aerospace shareholders after the company reported a wider loss and lower revenue in its first earnings report since going public.

FLY - Stock fell 15.3% after reporting wider losses and lower revenue in its first earnings report, suggesting poor financial performance and potential misleading business information

#securities claims #investor losses #earnings report #stock market

ROSEN, A LONGSTANDING FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A LONGSTANDING FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

11/09/2025 10:41 PM • Rosen Law Firm alerts James Hardie Industries investors about a potential securities class action lawsuit alleging the company misled investors about its North America Fiber Cement segment's performance between May and August 2025.

AMZN - Showed stock price increase of 3.99%, indicating market optimism
JHX - The lawsuit alleges the company falsely claimed demand was strong and stock levels were 'normal' despite knowing distributors were destocking inventory, suggesting potential intentional misrepresentation of financial performance

#securities class action #investor rights #misleading statements #stock performance

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); Inspire Medical Systems, Inc. (NYSE: INSP); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf

GlobeNewswire Inc. • Grabar Law Office

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); Inspire Medical Systems, Inc. (NYSE: INSP); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf

11/09/2025 08:34 PM • Law firm investigating potential securities fraud and fiduciary duty breaches for shareholders of Avantor, Humana, Inspire Medical Systems, and Maison Solutions, alleging misleading statements and undisclosed material facts.

AVTR - Allegations of making false statements about competitive positioning and experiencing negative effects from increased competition

#securities fraud #shareholder investigation #fiduciary duties #class action

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Super One Planned to Enter the Pilot Build and Production Phase at its Hanford Manufacturing Facility as First Batch of Complete Sets of Parts Scheduled to Arrive in the U.S. as Ear

GlobeNewswire Inc. • Yt Jia

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Super One Planned to Enter the Pilot Build and Production Phase at its Hanford Manufacturing Facility as First Batch of Complete Sets of Parts Scheduled to Arrive in the U.S. as Ear

11/09/2025 06:54 PM • Faraday Future plans to enter pilot build and production phase for FX Super One, with first parts shipment scheduled for November 15, 2025. The company filed a blockchain-based car sharing patent and is preparing to release Q3 2025 financial results.

FFAI - Company is making progress on vehicle production, filing innovative patents, and showing strategic planning for future growth

#electric vehicle #blockchain #car sharing #pilot production #patent

ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

11/09/2025 06:36 PM • Rosen Law Firm has filed a class action lawsuit against Inspire Medical Systems for allegedly misrepresenting market demand and launch details of their Inspire V sleep apnea device during the period of August 6, 2024 to August 4, 2025.

GOOGL - Successfully navigated AI challenges, maintained search dominance, reported strong Q3 revenue growth of 16%, and seamlessly integrated generative AI
INSP - The lawsuit alleges the company misrepresented key facts about their Inspire V device, potentially misleading investors about market demand and launch readiness, which suggests potential corporate misconduct

#securities lawsuit #class action #sleep apnea device #investor claims

Gold ETFs: SPDR Gold Shares Offers Scale While AAAU Is More Affordable

The Motley Fool • Neha Chamaria

Gold ETFs: SPDR Gold Shares Offers Scale While AAAU Is More Affordable

11/09/2025 06:32 PM • Two gold ETFs, SPDR Gold Shares and Goldman Sachs Physical Gold ETF, offer investors different options for gold exposure. While SPDR has larger assets, Goldman Sachs provides a more cost-effective investment with a lower expense ratio.

TSM - World's leading chip foundry, critical to AI computing, reported 41% Q3 revenue growth, and positioned to capture future chip demand
AAAU - Lower expense ratio of 0.18%, competitive performance matching gold spot price, more affordable entry point for investors

#gold ETF #investment #physical gold #expense ratio #assets under management

Think It's Too Late to Buy This Leading Nuclear Start-Up? Here's Why There's Still Time.

The Motley Fool • Steven Porrello

Think It's Too Late to Buy This Leading Nuclear Start-Up? Here's Why There's Still Time.

11/09/2025 06:32 PM • Oklo, a nuclear start-up, has seen significant stock growth over 450% this year, targeting AI data centers with innovative small compact nuclear reactors. Despite being pre-revenue, the company shows potential through its specialized fuel technology and recent acquisition of Atomic Alchemy.

MELI - Dominant e-commerce and payment platform in Latin America, leveraging region's growth potential and building a strong market ecosystem
OKLO - Company has strong growth potential, innovative reactor technology, strategic acquisition, and support from tech leaders like Sam Altman. However, regulatory approval and revenue generation remain critical challenges.

#nuclear energy #AI data centers #small reactors #startup investment

Ensurge Micropower ASA - Mandatory Notice of Trade for Primary Insiders

GlobeNewswire Inc. • Ensurge Micropower Asa

Ensurge Micropower ASA - Mandatory Notice of Trade for Primary Insiders

11/09/2025 04:57 PM • Ensurge Micropower ASA completed a private placement raising NOK 100 million at NOK 0.90 per share, with key insiders and their associated companies participating in the offering.

ENMPY - The company successfully raised capital through a private placement, indicating financial activity without clear positive or negative implications

#private placement #insider allocation #share offering #capital raise

Ensurge Micropower ASA - Key information relating to possible repair issue/subsequent offering

GlobeNewswire Inc. • Na

Ensurge Micropower ASA - Key information relating to possible repair issue/subsequent offering

11/09/2025 04:51 PM • Ensurge Micropower ASA announced a private placement raising NOK 100 million at NOK 0.90 per share, with a potential subsequent offering of up to NOK 20 million, pending approval at an Extraordinary General Meeting in December 2025.

ROKU - Strong platform business with 17% year-over-year growth, profitable quarter, increasing consumer usage, and promising future revenue growth
ENMPY - The company is conducting a standard capital raising exercise through a private placement, which suggests financial strategy rather than indicating significant positive or negative market performance

#private placement #stock offering #capital raise #Norwegian company

Ensurge Micropower ASA – Private Placement successfully placed

GlobeNewswire Inc. • Ståle Bjørnstad

Ensurge Micropower ASA – Private Placement successfully placed

11/09/2025 04:47 PM • Ensurge Micropower successfully raised NOK 100 million through a private placement of 83,678,032 shares in Tranche 1 and a conditional allocation of 27,433,079 shares in Tranche 2, priced at NOK 0.90 per share. The proceeds will be used to expand the team, upgrade manufacturing capabilities, and support corporate development.

BABA - Well-positioned in e-commerce, developing competitive AI chips, trading at reasonable earnings multiple, and expected to benefit from China's AI and technology investments
ENMPY - Successfully raised capital, expanding team and manufacturing capabilities, demonstrating strategic growth and financial strength

#private placement #share offering #microbattery technology #capital raise

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

11/09/2025 02:31 PM • Rosen Law Firm is investigating potential securities claims against Telix Pharmaceuticals after the company received an SEC subpoena related to prostate cancer therapeutic candidate disclosures, which caused a 10.44% stock price drop.

ATLCY - Mentioned as a partner in the project with no specific performance details provided
TLX - Received SEC subpoena questioning disclosure practices, experienced significant stock price decline, potential legal action by investors suggesting potential misconduct or transparency issues

#securities claim #subpoena #investor losses #prostate cancer therapeutics

KBR 9-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms–Hagens Berman

GlobeNewswire Inc. • Hagens Berman

KBR 9-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms–Hagens Berman

11/09/2025 11:24 AM • KBR faces a class-action lawsuit alleging misleading statements about its HomeSafe Alliance joint venture with TRANSCOM, which was terminated due to operational issues, causing significant revenue reduction and stock price decline.

KBR - Company experienced contract termination, significant revenue guidance reduction, stock price drop, and potential legal liability from misleading investor communications

#securities lawsuit #contract termination #revenue guidance #investor fraud

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.

The Motley Fool • Patrick Sanders

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.

11/09/2025 11:05 AM • The article discusses three healthcare stocks with strong dividend yields above the sector's average of 1.8%, highlighting AbbVie, UnitedHealth Group, and CVS Health as attractive dividend investment options.

NVO - Competing with Pfizer for Metsera acquisition, signaling strong interest in obesity drug market
ABBV - Strong revenue growth from Skyrizi and Rinvoq, 20% stock price increase in the year, and a 3.1% dividend yield with a 5.5% dividend increase

#healthcare #dividend #stocks #pharmaceutical #healthcare insurance

Weekend Tech Round-Up: Nvidia's AI Chip Sale To China Blocked, Apple's Billion-Dollar Deal With Google And More

Benzinga • Ananya Gairola

Weekend Tech Round-Up: Nvidia's AI Chip Sale To China Blocked, Apple's Billion-Dollar Deal With Google And More

11/09/2025 10:19 AM • The tech industry saw significant developments including the Trump administration blocking Nvidia's AI chip sale to China, Apple's billion-dollar deal with Google to power Siri, and Meta's massive $600 billion AI investment in the US.

NVDA - US government blocked sale of latest AI chip to China, potentially limiting market expansion

#AI #tech industry #chip sales #technology investment

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

11/09/2025 10:09 AM • Zions Bancorporation announced a $50 million charge-off due to loan irregularities, leading to a 13.14% stock price drop and potential securities class action lawsuit.

ZION - Announced a significant $50 million loan charge-off, experienced substantial stock price decline, and is facing potential legal action due to alleged misrepresentations and contractual defaults

#securities lawsuit #loan charge-off #investor losses

Artificial General Intelligence Is Coming: 1 Unstoppable Vanguard ETF to Buy Now

The Motley Fool • Todd Shriber

Artificial General Intelligence Is Coming: 1 Unstoppable Vanguard ETF to Buy Now

11/09/2025 10:03 AM • The article discusses the potential of Artificial General Intelligence (AGI) and highlights the Vanguard Information Technology ETF as a strategic investment vehicle for potential AI technological advancements, noting that while AGI is currently theoretical, it could have significant future implications.

VGT - ETF offers broad exposure to tech companies potentially benefiting from AI development, has low fees, and includes key AI-related companies in its portfolio

#Artificial General Intelligence #AGI #AI investing #technology ETF #semiconductors

Has Palantir Technologies Become a Better Artificial Intelligence (AI) Stock to Buy Than Nvidia?

The Motley Fool • David Jagielski

Has Palantir Technologies Become a Better Artificial Intelligence (AI) Stock to Buy Than Nvidia?

11/09/2025 09:35 AM • Palantir Technologies reported strong Q3 results with accelerating growth, beating analyst expectations and raising full-year guidance. While showing impressive performance, the article suggests Nvidia remains a more stable investment due to more reasonable valuation.

VYLD - CEO's comments highlighted potential broader market risks, but not directly negative about the company itself
PLTR - Strong quarterly results, 63% year-over-year revenue growth, raised full-year guidance, 152% returns in the year

#AI #technology stocks #quarterly earnings #stock performance #investment analysis

CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit

11/09/2025 09:30 AM • Faruqi & Faruqi is investigating potential claims against Cytokinetics regarding misleading statements about their New Drug Application (NDA) submission for aficamten, alleging the company failed to disclose material risks related to regulatory process requirements.

CYTK - The company is accused of making false and misleading statements about its drug approval timeline, potentially misleading investors and causing significant stock losses by omitting critical regulatory information about REMS submission

#securities litigation #class action #FDA #NDA #aficamten

ROSEN, THE FIRST FILING FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KMX

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, THE FIRST FILING FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KMX

11/09/2025 09:29 AM • Rosen Law Firm filed a class action lawsuit against CarMax for allegedly making false and misleading statements about its growth prospects during the period of June 20, 2025 to November 5, 2025.

KMX - The lawsuit alleges that CarMax management recklessly overstated growth prospects and made materially false statements about the company's business, operations, and prospects, suggesting potential financial misrepresentation

#securities lawsuit #class action #investor rights #false statements

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS

11/09/2025 09:27 AM • Rosen Law Firm filed a class action lawsuit against Synopsys, alleging the company made false or misleading statements about its business operations, particularly regarding artificial intelligence customer impacts and financial performance during December 2024 to September 2025.

CIFRW - The company is seeking significant financing for infrastructure expansion, which indicates strategic growth but also potential financial complexity
SNPS - Lawsuit claims company made materially false statements about business operations, specifically regarding AI customer economics and potential negative financial impacts, suggesting potential misconduct or misrepresentation

#securities lawsuit #class action #artificial intelligence #investor rights

TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

11/09/2025 09:18 AM • Tvardi Therapeutics experienced an 80% stock drop after disappointing Phase 2 clinical trial results for TTI-101 in idiopathic pulmonary fibrosis, with preliminary data showing the study did not meet its goals.

GOOG - Mentioned as providing warrant pledges, with no direct negative or positive implications
TVRD - Stock plummeted over 80% due to unsuccessful clinical trial results, indicating poor performance and potential investor losses

#clinical trial #pharmaceutical #stock drop #investor investigation